Literature DB >> 17172928

Assessment of right ventricular infarction with contrast-enhanced magnetic resonance imaging.

Theodorus A M Kaandorp1, Hildo J Lamb, Don Poldermans, Eric P Viergever, Eric Boersma, Ernst E van der Wall, Albert de Roos, Jeroen J Bax.   

Abstract

OBJECTIVE: Evaluation of contrast-enhanced magnetic resonance imaging to assess right ventricular infarction in patients with acute inferior myocardial infarction.
BACKGROUND: Contrast-enhanced magnetic resonance imaging has been used for assessing scar tissue after left ventricular infarction. The value of contrast-enhanced magnetic resonance imaging to assess right ventricular infarction is unknown and was evaluated.
METHODS: Consecutive patients (n=18) with first acute inferior infarction were included. Resting electrocardiogram and right-sided electrocardiogram were acquired to assess right ventricular involvement. Resting cine magnetic resonance imaging was performed to evaluate right ventricular function and volumes, whereas the extent of right ventricular scar tissue was assessed by contrast-enhanced magnetic resonance imaging. Cine magnetic resonance imaging was repeated at 6-months follow-up to re-assess right ventricular function and volumes.
RESULTS: Sensitivity and specificity of magnetic resonance imaging were 100 and 78%, respectively, to detect right ventricular infarction (using the right-sided electrocardiogram as the gold standard). At 6 months follow-up, patients with scar tissue on contrast-enhanced magnetic resonance imaging showed right ventricular dilatation. Moreover, the extent of right ventricular scar tissue was linearly related to the severity of right ventricular dilatation.
CONCLUSIONS: Contrast-enhanced magnetic resonance imaging permits accurate assessment of right ventricular scar tissue. Patients with extensive right ventricular infarction demonstrate right ventricular dilatation at 6 months follow-up.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172928     DOI: 10.1097/MCA.0b013e32801104c1

Source DB:  PubMed          Journal:  Coron Artery Dis        ISSN: 0954-6928            Impact factor:   1.439


  7 in total

1.  Primary reperfusion in acute right ventricular infarction: An observational study.

Authors:  Eulo Lupi-Herrera; Héctor González-Pacheco; Ursulo Juárez-Herrera; Nilda Espinola-Zavaleta; Eduardo Chuquiure-Valenzuela; Ramón Villavicencio-Fernández; Marco Antonio Peña-Duque; Ernesto Ban-Hayashi; Sergio Férez-Santander
Journal:  World J Cardiol       Date:  2014-01-26

2.  Utility of cardiac magnetic resonance (CMR) in the evaluation of right ventricular (RV) involvement in patients with myocardial infarction (MI).

Authors:  Nicola Galea; Marco Francone; Iacopo Carbone; David Cannata; Francesco Vullo; Roberto Galea; Luciano Agati; Francesco Fedele; Carlo Catalano
Journal:  Radiol Med       Date:  2013-12-12       Impact factor: 3.469

Review 3.  The use of cardiovascular magnetic resonance in acute myocardial infarction.

Authors:  Hassan Abdel-Aty; Christoph Tillmanns
Journal:  Curr Cardiol Rep       Date:  2010-01       Impact factor: 2.931

Review 4.  Cardiac MR imaging: current status and future direction.

Authors:  Maythem Saeed; Tu Anh Van; Roland Krug; Steven W Hetts; Mark W Wilson
Journal:  Cardiovasc Diagn Ther       Date:  2015-08

Review 5.  The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease.

Authors:  Sophie Mavrogeni; George Papadopoulos; Tarique Hussain; Amedeo Chiribiri; Rene Botnar; Gerald F Greil
Journal:  Int J Cardiovasc Imaging       Date:  2013-08-15       Impact factor: 2.357

6.  The role of cardiac magnetic resonance in the evaluation of patients presenting with suspected or confirmed acute coronary syndrome.

Authors:  Loren P Budge; Michael Salerno
Journal:  Cardiol Res Pract       Date:  2011-10-19       Impact factor: 1.866

Review 7.  Use of cardiovascular magnetic resonance imaging in acute coronary syndromes.

Authors:  Tim Lockie; Eike Nagel; Simon Redwood; Sven Plein
Journal:  Circulation       Date:  2009-03-31       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.